A comparative performance analysis of total prostate-specific antigen, percentage free prostate-specific antigen, prostate-specific antigen velocity and urinary prostate cancer gene 3 in the first, second and third repeat prostate biopsy Academic Article uri icon


MeSH Major

  • Antigens, Neoplasm
  • Prostate-Specific Antigen
  • Prostatic Neoplasms


  • The findings of the present study promote the concept that the number of previous repeat biopsy sessions strongly influences the performance characteristics of biopsy risk factors. Total PSA was no significant risk factor in the entire analysis. By contrast, %fPSA performed best at second and ≥ third repeat biopsy. PSAV's diagnostic potential was reserved to patients at second and ≥ third repeat biopsy. Finally, PCA3 demonstrated the highest diagnostic accuracy and potential to reduce unnecessary biopsies at first repeat biopsy. However, this advantage dissipated at second and ≥ third repeat biopsy.

publication date

  • June 2012



  • Academic Article



  • eng

Digital Object Identifier (DOI)

  • 10.1111/j.1464-410X.2011.10584.x

PubMed ID

  • 21939492

Additional Document Info

start page

  • 1627

end page

  • 35


  • 109


  • 11